Company profile: C-Lecta
1.1 - Company Overview
Company description
- Provider of enzyme engineering and bioprocess development for regulated markets, developing, manufacturing, and commercializing application-oriented enzyme variants. Offers the ENESYZ technology platform for customized enzymes and microbial production strains, enzymes for food and pharmaceutical industries, and biocatalytic products that replace complex chemical processes.
Products and services
- ENESYZ Technology Platform: c-LEcta’s proprietary, custom-engineered platform that develops tailored enzymes and microbial production strains for varied industrial manufacturing processes, enabling application-oriented variants via own and cooperative development
- Pharmaceutical Industry Enzymes: Regulated-market pharmaceutical enzymes that contribute to production of new therapies and synthesis of APIs, architected to integrate into bioprocess development for regulated-market therapeutics manufacturing
- Food Industry Enzymes: Industrial-grade food enzymes used in the production of food ingredients and additives or as process aids, engineered for application-oriented performance in regulated manufacturing contexts
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to C-Lecta
Healionics
HQ: United States
Website
- Description: Provider of synthetic vascular grafts and platform biomaterial scaffolds for dialysis patients and tissue regeneration. Offers STARgraft for reliable bloodstream access with resistance to occlusion and infection, and STAR Biomaterial with specific pore structure to enable angiogenesis and minimize foreign body response.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Healionics company profile →
Crawford Scientific
HQ: United Kingdom
Website
- Description: Provider of chromatography consumables and products (columns, vials, syringe filters, gas generators), analytical services, and chromatography/mass spectrometry training, offering HPLC columns, technical support and consultancy, online training courses, and the CHROMacademy eLearning platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crawford Scientific company profile →
BrainBox Solutions
HQ: United States
Website
- Description: Provider of objective evidence of injury and prediction of patient recovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BrainBox Solutions company profile →
MILabs
HQ: The Netherlands
Website
- Description: Provider of high-end molecular imaging solutions for biomedical research, including systems for quantitative 3D functional imaging of SPECT (U-SPECT) and PET (U-PET) tracers, an integrated PET/SPECT platform for simultaneous high-resolution imaging (VECTor), and automated quantitative 3D autoradiography of tissue samples with multiple isotopes (EXIRAD-3D).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MILabs company profile →
Scireq
HQ: Canada
Website
- Description: Provider of laboratory equipment for preclinical respiratory research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scireq company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for C-Lecta
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to C-Lecta
2.2 - Growth funds investing in similar companies to C-Lecta
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for C-Lecta
4.2 - Public trading comparable groups for C-Lecta
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →